Compare Fastly Inc (FSLY) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fastly Inc vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Fastly Inc trades at $24.63 (market cap $4.32B), while GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 7.2× Fastly Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Fastly Inc pays none. Which is the better fit depends on your goals.
| FSLY | GEHC | |
|---|---|---|
Market Cap | $4.32B | $31.07B |
Volume | 5,665,889 | 3,443,020 |
Sector | Technology | Health |
52-Week High | $33.50 | $88.16 |
52-Week Low | $7.86 | $59.48 |
Typical Hold Time | 26 Days | — |
Enterprise Value | $4.38B | $39.53B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fastly (FSLY) trades at $27.09, up 2.5% with bullish technical signals and strong earnings beats. The stock shows improving fundamentals with revenue growth from $544M to $624M (2024-2025) and narrowing losses. Recent investor day highlighted AI-driven growth targets of $1.1-1.3B revenue by 2029. Technical indicators show bullish moving averages with support at $25 and resistance at $28.
Outlook remains positive with analyst consensus at $28.33 target, though risks include persistent net losses and insider selling. The company's edge cloud platform benefits from AI traffic growth, but profitability challenges and competitive pressures require monitoring. Institutional sentiment is mixed with 33% buy ratings amid ongoing transformation.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Fastly Inc
Fastly operates a content delivery network, which is necessary for entities to provide faster and more reliable online content. Fastly's strategy differs from traditional CDNs, which focused on locating servers in as many locations as possible to store copies of files that consumers most use. Fastly has far fewer sites than traditional CDNs, but it houses servers in the most network-dense data centers. Instead of simply storing static content, it allows its customers to program on its platform, enabling edge computing and better service of the more dynamic content that was traditionally not well served by CDNs. Fastly gears its service to the largest, most sophisticated enterprises rather than small companies and generated about two thirds of its revenue in the United States in 2020.
Read more on FSLY →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
